Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

+44 1478 350008

Research Article - (2023)Volume 14, Issue 1

Association between the MTHFR 677C/T Polymorphism and Susceptibility to Psoriasis: An Updated Meta-Analysis

Junhua Qi1, Yu Zhang2, Lvya Zhang2 and Gang Nie2*
 
*Correspondence: Gang Nie, Department of Dermatovenereology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518107, China, Email:

Author info »

Abstract

The correlation between psoriasis and Methylenetetrahydrofolate Reductase (MTHFR) 677C/T polymorphism has been examined in a number of studies. However, the findings remain ambiguous. The present meta-analysis was conducted to comprehensively evaluate this issue. Eligible studies were searched in EMBASE, PubMed, Web of Science, Wan Fang Database, and Chinese National Knowledge Infrastructure (CNKI) up to December 31, 2021. Pooled Odds Ratios (ORs) with 95% Confidence Intervals (CIs) were calculated to estimate the effects of the MTHFR 677C/T polymorphism on psoriasis risk in different genetic models. Eleven relevant case-control studies were included in our meta-analysis, involving 2010 psoriasis cases and 1881 healthy controls. Pooled analysis suggested that the MTHFR 677C/T polymorphism was associated with increased psoriasis risk in the recessive model (TT vs. TC+CC, OR1.69, 95%CI=1.09-2.61, P=0.020). Stratification by ethnicity indicated that the MTHFR 677C/T polymorphism was associated with increased psoriasis risk in Asians under the recessive model (TT vs. TC+CC, OR=1.64, 95%CI=1.01-2.67, P=0.046) and in Europeans under the allelic model (T vs. C, OR=2.57, 95%CI=1.02- 6.48, P=0.046). In conclusion, the MTHFR 677C/T polymorphism may be associated with an increased psoriasis risk. The TT genotype may increase the risk of psoriasis in Asians. Allele might increase psoriasis risk in Europeans.

Keywords

MTHFR; Polymorphism; Psoriasis; Meta-analysis

Introduction

Psoriasis is a chronic and recurrent inflammatory disease which affects 1%-3% the world’s population [1]. The characteristic lesions of psoriasis are red papules or plaques covered with multiple layers of silvery white scales. Due to the chronic course and recurrent attacks, psoriasis can not only influence appearance, but also affect the physical health and psychological status of patients [2].

The precise pathogenesis of psoriasis is still unclear. However, it is widely accepted that multi-factors, including genetic predisposition, environment, and host immune response, were involved in the development and exacerbation of psoriasis [3].

Methylenetetrahydrofolate Reductase (MTHFR) is a key enzyme in the folate metabolic pathway. Its main function is to convert 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate with biological functions [4]. The human MTHFR gene is located on chromosome 1p36.3, a region in which many Single Nucleotide Polymorphisms (SNPs) have been identified. The polymorphism at position 677 in MTHFR gene has been extensively investigated in psoriasis, which substitutes nucleotide C with to T, resulting in the reduced activity of the enzyme and increased homocysteine levels [5].

Despite the fact that MTHFR polymorphism has been linked to psoriasis in a number of studies, the results are still inconclusive. This is partly because the studies' sample sizes, statistical power, clinical heterogeneity, and diverse ethnic populations made it difficult to draw firm conclusions. In this study, we quantified the associations between the MTHFR polymorphism and psoriasis using a thorough meta-analysis. Additionally, we performed subgroup analyses to evaluate the impacts of the variables that might change this association.

Materials and Methods

Search strategy

Eligible studies were independently searched from EMBASE, PubMed, Web of Science, Wan Fang Database, and Chinese National Knowledge Infrastructure (CNKI) by two authors up to 31 December 2021, using the following keywords: (“Methylenetetrahydrofolate Reductase” or “MTHFR”) and (“psoriatic” or “psoriasis”) and (“Single Nucleotide Polymorphism” or “SNP” or “polymorphism” or “mutation” or “variation”). We included only Chinese and English language studies. The reference lists of included studies were manually searched to obtain additional related studies.

Criteria for inclusion and exclusion

We ran a preliminary screening of all the literature based on titles and abstracts. Based on the inclusion criteria, we read the literature that was identified in the preliminary screen and acquired the final included literature. Studies were included if they met the following criteria: (1) Were case-control studies; (2) Were studies that documented the association between 677C/T polymorphism in the MTHFR gene and psoriasis susceptibility; (3) Were studies that had available data to calculate 95% Confidence Intervals (CIs) for Odds Ratios (ORs). Correspondingly, the following studies were excluded for any of the following: (1) Were duplications; (2) Were not casecontrol studies; (3) Were not related to the association between 677C/T polymorphism in the MTHFR gene and psoriasis susceptibility; (4) Lacked the available data to calculate OR and 95%CI; (5) The genotype distributions of healthy controls were not consistent with the Hardy-Weinberg Equilibrium (HWE).

Data extraction

Eligible studies were extracted by two authors according to the inclusion and exclusion criteria. The following information was extracted by two investigators independently: First author, publication year, country, ethnicity, genotype distribution in cases and controls. Disagreements were settled through discussion between the authors.

Statistical analysis

The genotype distributions of healthy controls were tested by Pearson’s χ2 test, and P<0.05 was regarded as diverging from HWE [6]. Cochran Q-statistics and the I2 test were used to check the heterogeneity between studies [7-8]. P<0.1 or I2>50% indicated that there was potential heterogeneity. Random-effect model or fixed-effect model was applied to calculate ORs with corresponding 95%CIs according to the presence or absence of heterogeneity. Sensitivity analysis, carried out by sequentially excluding a single individual study, was used to evaluate the robustness of results. Both Begg’s funnel plot and Egger’s test were performed to investigate the potential publication bias in the present meta-analysis. All statistical tests were conducted using STATA 12.0 software (Stata Corporation, College Station, Texas).

Results

Characteristics of included studies

A flow chart displaying the process of selection study or exclusion study is shown in Figure 1. 11 relevant case-control studies were included in this meta-analysis, involving 2010 psoriasis cases and 1881 healthy controls [9-19]. The publication year ranged from 2000 to 2018. The characteristics of the included studies and genotype distributions are summarized in Table 1.

Study Year Country Ethnicity Case Control HWE
CC CT TT CC CT TT
Baiqiu [16] 2000 China Asian 8 19 12 26 43 10 0.23
Jie 2007 China Asian 26 59 38 21 73 35 0.099
Weger [14] 2008 Austria European 133 130 47 110 108 29 0.752
Vasku [10] 2009 Czech European 195 175 40 90 125 29 0.147
Dehui [18] 2012 China Asian 60 34 14 42 47 13 0.979
Liew [11] 2012 Malaysia Asian 159 41 0 125 40 2 0.543
Xiao-bing 2014 China Asian 65 39 16 43 45 12 0.966
Asefi [12] 2014 Iran Asian 50 43 7 64 35 1 0.108
Kilic [15] 2016 Turkey European 32 42 10 207 5 0 0.862
Izmirli [9] 2016 Turkey European 34 46 16 39 35 3 0.152
Luo [13] 2018 China Asian 210 169 41 279 129 16 0.821

Table 1: Characteristics of studies included in the meta-analysis.

exclusion

Figure 1: The flow chart of the selection of studies and specific reasons for exclusion from the meta-analysis.

Meta-analysis results

Q-test and the I2 test indicated there is obvious heterogeneity between studies in the comparisons of T vs. C, TT vs. CC, TC vs. CC, TT+TC vs. CC and TT vs. TC+CC (P<0.1 or I2>50%) (Table 2 and Figure 2). Therefore, we used the random effects model to calculate the results. The results of meta-analysis showed that there was no association between MTHFR 677C/T polymorphism and psoriasis in the comparisons of T vs. C, TT vs. CC, TC vs. CC and TT+TC vs. CC, but a significant association in the comparison of TT vs. TC+CC (OR=1.69, 95% CI=1.09-2.61, P=0.020) (Table 2 and Figure 2).

Comparison OR 95%CI P-value Heterogeneity PBegg's PEgger's
I2 P-value
T vs. C 1.44 1.00-2.09 0.051 91.20% 0 P>0.05 P>0.05
Asian 1.14 0.81-1.60 0.455 81.70% 0
European 2.57 1.02-6.48 0.046 96.30% 0
TT vs. CC 1.76 0.97-3.19 0.063 77.60% 0 P>0.05 P>0.05
Asian 1.54 0.75-3.13 0.239 70.80% 0.002
European 2.66 0.78-9.10 0.119 87.00% 0
TC vs. CC 1.27 0.79-2.03 0.331 89.70% 0 P>0.05 P>0.05
Asian 0.93 0.61-1.44 0.761 77.50% 0
European 2.43 0.74-8.04 0.145 95.80% 0
TT+TC vs. CC 1.41 0.87-2.31 0.165 91.20% 0 P>0.05 P>0.05
Asian 1.03 0.65-1.62 0.898 81.50% 0
European 2.76 0.81-9.42 0.105 96.40% 0
TT vs. TC+CC 1.69 1.09-2.61 0.02 65.10% 0.001 P>0.05 P>0.05
Asian 1.64 1.01-2.67 0.046 50.80% 0.058
European 2.12 0.80-5.58 0.128 80.60% 0.001

Table 2: Meta-analysis of the association between MTHFR 677C/T polymorphism and psoriasis susceptibility.

polymorphism

Figure 2: Forest plot for the association between the MTHFR 677C/T polymorphism and psoriasis susceptibility: T vs. C (A), TT vs. CC (B), TC vs. CC (C), TT+TC vs. CC (D), TT vs. TC+CC (E). CI: Confidence Interval; OR: Odds Ratio.

Subgroup analysis

In the subgroup analysis, the included studies were divided into Asian and European populations based on ethnicity. In Asian populations, the results of meta-analysis showed that there was no association between MTHFR 677C/T polymorphism and psoriasis in the comparisons of T vs. C, TT vs. CC, TC vs. CC and TT+TC vs. CC, but significant association in the comparison of TT vs. TC+CC (OR=1.64, 95%CI=1.01-2.67, P=0.046) (Table 2 and Figure 2). In European populations, the results of metaanalysis showed that there was no association between MTHFR 677C/T polymorphism and psoriasis in the comparisons of TT vs. CC, TC vs. CC, TT+TC vs. CC and TT vs. TC+CC, but a significant association in the comparison of T vs. C (OR=2.57, 95%CI=1.02-6.48, P=0.046) (Table 2 and Figure 2).

Publication bias

Egger’s test and Begg’s funnel plot (Figure 3) suggested that there was a lack of significant publication bias in all genetic models (all P>0.05).

funnel

Figure 3: Begg’s funnel plot test of publication bias for the association between the MTHFR 677C/T polymorphism and psoriasis susceptibility: T vs. C (A), TT vs. CC (B), TC vs. CC (C), TT+TC vs. CC (D), TT vs. TC+CC (E).

Sensitivity analysis

The sensitivity analysis was carried out by sequentially excluding a single individual study. The results were not significantly altered in all genetic models (Figure 4), indicating the stability of our results.

Sensitivity

Figure 4: Sensitivity analysis of the summary Odds Ratio (OR) on the association between the MTHFR 677C/T polymorphism and psoriasis susceptibility: T vs. C (A), TT vs. CC (B), TC vs. CC (C), TT+TC vs. CC (D), TT vs. TC+CC (E).

Discussion

The precise etiology of psoriasis is yet unclear, genetic predisposition, cell-mediated adaptive immune response, cigarette smoking, and other as-yet-unidentified psychosocial factors appear to interact or operate singly in the disease. Recent advances in the large-scale analysis of human genetic loci have generated valuable insights into possible genetic contributions to psoriasis. Many susceptibility genes or loci have been identified for psoriasis by the wide application of Genome- Wide Association Studies (GWASs) [20].

MTHFR C677T polymorphism has been studied with conflicting results regarding its potential value for psoriatic patients. Although two meta-analysis was performed in 2015 to investigate the association between MTHFR 677C/T polymorphism and psoriasis risk, no significant relationship between MTHFR 677C/T polymorphism and psoriasis risk was found [21,22]. In addition, there were only 5 studies and 7 studies in these two meta-analyses, respectively. Due to the emergence of novel studies, an updated meta-analysis on recent evidences is necessarily needed.

In our present meta-analysis, there were 11 studies, 2010 cases and 1881 controls that we evaluated for the possible association between MTHFR 677C/T polymorphism and psoriasis risk. Our results indicate that MTHFR C677T polymorphism does not correlate with the risk of psoriasis in the comparisons of T vs. C, TT vs. CC, TC vs. CC and TT+TC vs. CC under the random-effect model, but there is a significant relationship with susceptibility of psoriasis in the comparison of TT vs. TC+CC under the random-effect model, which indicates that TT genotype might increase psoriasis risk than either CC or TC genotype. Subgroup analysis by ethnicity was conducted with the ethnicity being primarily defined as Asian and European. Stratified analysis indicated that MTHFR 677C/T polymorphism was associated with increased psoriasis risk in Asian under the recessive model (TT vs. TC+CC, OR=1.64, 95%CI=1.01-2.67, P=0.046) and in European under the allelic model (T vs. C, OR=2.57, 95% CI=1.02-6.48, P=0.046). Our meta-analysis showed strong evidence to support a connection between the MTHFR 677C/T polymorphism and psoriasis risk when compared to earlier meta-analysis [21,22].

The MTHFR C677T polymorphism has been implicated in the pathogenesis of esophageal cancer [23], hypertension [24], psychiatric disorders [25], and cervical artery dissections [26]. However, it has not been linked to prostate cancer [27], lung cancer [28], polycystic ovary syndrome [29], osteoporotic fractures [30], open-angle glaucoma [31] and ovarian cancer [32]. When taken as a whole, the findings show that various diseases develop along distinct pathological pathways, and that MTHFR's roles in various pathologies are influenced by the genes it targets.

Additionally, the MTHFR C677T polymorphism may, to some extent, quantitatively reflect the severity of psoriasis. According to a cross-sectional study by Karabacak, et al. [33], there may be a link between the MTHFR polymorphism and the severity of psoriasis.

In summary, the MTHFR C677T polymorphism is a genetic factor in the etiology of psoriasis and may, to some extent, reflect the severity of the disease. Some advantages were found in our meta-analysis. First, publication bias, a substantial problem for the credibility of the research, was not found in the analysis. Second, the sensitivity analysis suggested that the results were robust. Third, by adding additional studies, we expanded the number of pooled samples. All above-mentioned advantages revealed that the results were relatively reliable. However, some unavoidable limitations of our meta-analysis should not be ignored. First, the results show that there is obvious heterogeneity between the studies, which indicates that there may be ethnic differences in the subjects' genetic background and living environment. Second, the publications included were limited to Asian and European populations, so future work should study other populations. Third, gene linkage effects and gene-environment interaction effects were not analyzed.

Conclusion

Our meta-analysis demonstrated that MTHFR 677C/T polymorphism might be associated with increased psoriasis risk. TT genotype might increase psoriasis risk in Asian. Allele might increase psoriasis risk in European. Larger and well-designed studies are still needed to verify these results.

Conflict of Interest

The authors declare that they have no conflict of interest.

Authors' Contribution

Gang Nie conceived and designed this study. Junhua Qi and Yu Zhang conducted the systematic literature review. Lvya Zhang performed data analyses. Junhua Qi drafted the manuscript. Gang Nie revised manuscript critically. All authors reviewed the manuscript.

Availability of Data and Materials

All the data available upon request to the corresponding author.

References

Author Info

Junhua Qi1, Yu Zhang2, Lvya Zhang2 and Gang Nie2*
 
1Department of Clinical Medical Laboratory, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518107, China
2Department of Dermatovenereology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518107, China
 

Citation: Qi J, Zhang Y, Zhang L, Nie G (2023) Association between the MTHFR 677C/T Polymorphism and Susceptibility to Psoriasis: An Updated Meta- Analysis. J Clin Exp Dermatol Res. 14:624.

Received: 20-Jan-2023, Manuscript No. JCEDR-23-21480; Editor assigned: 23-Jan-2023, Pre QC No. JCEDR-23-21480 (PQ); Reviewed: 06-Feb-2023, QC No. JCEDR-23-21480; Revised: 13-Feb-2023, Manuscript No. JCEDR-23-21480 (R); Published: 20-Feb-2023 , DOI: 10.35841/2155-9554.23.14.624

Copyright: © 2023 Qi J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top
https://www.olimpbase.org/1937/